Value Line has launched a fresh $2 million stock-buyback program, signaling a commitment to returning capital to shareholders. The initiative, which takes effect immediately, replaces a previous authorization from October 2025 and operates without a fixed expiration date or specific price constraints on open-market purchases.
A volatile week for technology investors closed on a sour note Friday, as a persistent selloff in semiconductor shares coincided with a sharp decline in Netflix stock. Meanwhile, geopolitical friction between the U.S. and Iran sent oil prices climbing, further unsettling a market already reeling from cooling enthusiasm for AI spending.
Tucson-based NuvOx Therapeutics is moving to public markets, seeking to raise up to $20.2 million through an initial public offering. The clinical-stage biopharmaceutical firm plans to list 2.9 million shares on the NYSE American under the ticker symbol NUOX, pricing the equity between $6 and $8 per share.
A deepening selloff in semiconductor stocks dragged the Nasdaq composite down 1% today, as investors reassess whether massive capital expenditures on artificial intelligence can support current market valuations. The decline follows a volatile session in Asian markets and a sharp retreat in shares of major industry players.
A relentless selloff in chip stocks dragged the Nasdaq composite down by 1% Friday, as investors retreated from high-valuation tech firms. The downturn follows a broader global slump that saw benchmark indexes in Taiwan and Japan tumble by 6.5% and 4% respectively, signaling deepening anxiety over the sustainability of AI capital expenditures.
Escalating military friction between the U.S. and Iran has sent energy markets into a sharp rally, with crude oil prices climbing more than 2% Friday morning. The intensification of strikes across the Middle East, including attacks on Kuwaiti infrastructure, puts contracts on track for significant weekly gains.
Shoppers across Canada are being urged to discard Heavenly Spices brand garlic powder after the discovery of Bacillus cereus, a bacterium capable of causing food poisoning. Dollarama has issued a national recall for the 70-gram containers, which were sold both in retail locations and through the company's online store.
Amazon’s autonomous vehicle unit, Zoox, has recalled its entire fleet of 105 robotaxis after discovering a software glitch that blinds the vehicles to heavy smoke. The defect, which poses a significant collision risk near emergency scenes, forced a swift remote update to address the critical visibility failure.
Investors pushed Docebo shares up by more than 8% Friday after the AI-driven training platform announced a $70 million share repurchase program. The move follows strong preliminary second-quarter results that topped market expectations, signaling confidence in the company’s ongoing growth trajectory and future cash flow stability.
Investors sent Regenxbio shares tumbling 13% to $9.69 on Friday morning, following the biotechnology firm’s decision to launch a $100 million public offering. The sharp decline deepens a broader downward trend for the company, which has seen its market value erode by roughly 31% over the last six months.
Maria Luis Albuquerque, the bloc's financial services commissioner, announced a strategic push to modernize European banking regulations by early 2027. The initiative aims to sharpen the continent's economic edge, ensuring regional lenders possess the agility required to challenge dominant international rivals in an increasingly demanding and volatile global marketplace.
A sharp retreat in semiconductor stocks dragged the Nasdaq composite down nearly 2% during Friday’s early trading session. The decline follows a broader market slump in Asia and mounting investor anxiety over whether current artificial intelligence spending can sustain the high valuations of major industry players.
Shares of Kalaris Therapeutics surged 17% to $5.39 Tuesday morning, extending a year-long rally that has seen the stock price more than double. The jump follows the release of expanded Phase 1a trial data for TH103, an experimental treatment targeting neovascular age-related macular degeneration that continues to show clinical promise.
A premium price of $20.40 per share is on the table as Docebo initiates a substantial issuer bid to repurchase up to $70 million of its stock. The Toronto-based training platform, which counts Intercap as a majority stakeholder, aims to leverage increased credit facilities to fund the buyback while maintaining growth capital.
A consortium led by Aecon Group has secured an 815 million Canadian dollar contract to overhaul Winnipeg’s oldest and largest wastewater treatment facility. The project, aimed at upgrading the North End Water Pollution Control Centre, marks a significant infrastructure push to modernize the city’s aging environmental processing capabilities.
Nano Dimension will vacate its corporate headquarters by the end of the year, cutting short a lease agreement that was not set to expire until 2031. The decision marks a deliberate shift by management to trim operational spending following a series of recent divestitures aimed at stabilizing the company’s financial position.
Kimbell Royalty Partners is set to expand its footprint in the nation’s most prolific energy basins, announcing a $215.4 million acquisition of oil and gas royalties from affiliated sellers. The transaction marks a strategic consolidation of assets across four major shale regions, signaling a move to bolster its existing portfolio.
Maase is offloading its 49% indirect stake in Laixi Intelligent for $17 million to sharpen its focus on artificial intelligence. The divestiture of the unmanned car-wash business marks a deliberate shift for the company as it moves to consolidate capital and management oversight into its core technology infrastructure and large language model development.
A 42% interest in a BP unit tasked with redeveloping northern Iraq’s vast Kirkuk oil fields has been purchased by ConocoPhillips. The U.S. energy giant confirmed the agreement on Friday, stepping into a strategic contract that targets the rehabilitation of fields currently pumping crude in the volatile northern region.
San Diego-based BlossomHill Therapeutics has officially moved toward a public listing, filing registration documents with the U.S. Securities and Exchange Commission. The clinical-stage biopharmaceutical firm aims to trade its shares on the Nasdaq Global Select Market under the ticker symbol BLSM, though specific financial targets remain under wraps for now.
With net income climbing to $1.52 billion, Truist Financial outperformed Wall Street expectations in the second quarter. Driven by a robust performance in investment banking and trading, the North Carolina-based bank cleared $1.23 per share, comfortably surpassing the $1.08 forecast by analysts polled by FactSet.
Regions Financial reported a quiet second quarter, with profit and revenue growth stalling against shifting market demands. The banking group posted a net income of $570 million, marginally exceeding the previous year’s $563 million, though total revenue failed to gain momentum, landing at $1.91 billion for the period.
A 12% jump in Georg Fischer shares this morning signals investor relief as the Swiss industrial manufacturer raised its full-year sales guidance. The company, which specializes in piping and valve systems, pinned its newfound optimism on robust order intake from semiconductor manufacturers and the expanding data center sector.
Beijing has branded Donald Trump’s recent claims of Chinese election meddling as a calculated smear campaign, categorically denying any involvement in American democratic processes. Foreign ministry spokesman Lin Jian dismissed the rhetoric on Friday, insisting that China maintains a strict policy of non-interference regarding the internal political affairs of other nations.
A 24% single-day share drop for Z.AI has sent shockwaves through the Hong Kong market, triggered by the surprise launch of Moonshot AI’s Kimi K3. The new model’s reported benchmark superiority over Z.AI’s GLM 5.2 has shattered investor confidence, forcing a sharp revaluation of China’s leading independent AI labs.
A sharp 4% slide in Japan’s Nikkei 225 and a 3% drop in the Shanghai Composite signaled a broader retreat in global equities today, as the recent fervor surrounding artificial intelligence stocks faced a cooling period that rippled from Asian trading floors into Western futures.
A sharp reversal in fortunes saw Adjuvant Cosme Japan report a net profit of 61 million yen for the first quarter ending June 20, a significant climb from the 11 million yen recorded during the same period last year, according to the company’s latest financial disclosures.
Gendai Agency Inc. posted a net profit of 89 million yen for the first quarter ending June 30, a sharp decline from the 139 million yen reported during the same period last year. The results, filed under Japanese accounting standards, reflect a broader downturn across the company's key financial metrics.
After three years of stagnation, Burberry has finally broken its slump, reporting a 5% rise in comparable store sales for the first quarter ending June 27. The British luxury house is banking on this momentum to validate its internal turnaround strategy, even as global market conditions remain fraught with uncertainty.
South Korean prosecutors have raided the local office of Montage Technology, triggering a sharp selloff for the Chinese chipmaker. The investigation into alleged price-fixing of semiconductor components adds significant pressure to the firm, which relies on the South Korean market for more than half of its total revenue.
